Safety and PK of MBX-400 (Cyclopropavir) in Normal Volunteers
Clinical trial NCT02454699 · COMPLETED
Trial details
- NCT number
- NCT02454699
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-10
- Primary completion
- 2017-04-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.